Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Initial Treatment With Methotrexate in Large Granular Lymphocytic (LGL) Leukemia

NCT00003910 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00003910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Initial Treatment With Methotrexate in Large Granular Lymphocytic (LGL) Leukemia
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 2
Overall status
Terminated
Start date
September 15, 1999
Completion date
March 31, 2012
Enrollment
59 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia